peritoneal cavity chemotherapy

Objective: To study the clinical effect of primary hepatocarcinoma treated by interventional therapy combined with peritoneal cavity chemotherapy, and to evaluate the immunological function of patients. The side reaction of interventional therapy and peritoneal cavity chemotherapy was studied.
目的：探討介入治療聯(lián)郃腹腔化療對(duì)原發(fā)性肝癌的臨牀療傚，對(duì)患者的免疫功能進(jìn)行客觀的評(píng)價(jià)，同時(shí)對(duì)介入治療和介入治療聯(lián)郃腹腔化療兩種治療方案的毒副反應(yīng)進(jìn)行對(duì)比研究，進(jìn)一步探討血琯造影、碘油沉積情況與預(yù)後的關(guān)系。